- John Zarocostas
A1 Geneva
New guidance on the treatment of malaria released by the World Health Organization on 9 March recommends parasitological testing before treatment begins and adds a new artemisinin based combination treatment to the list of prescribed drugs.
The new guidelines are expected to enhance earlier and accurate diagnosis, halt the emergence of drug resistance, and reduce the use of unnecessary treatment.
Each year sees nearly 250 million cases of malaria and 860 000 deaths. About 85% of these deaths are of children, and most occur in Africa, says WHO.
The agency also released its first ever guidelines for good practice in the procurement and purchase of antimalarials. The guidelines are based on evidence of efficacy and safety and meet international standards.
“Prompt parasitological confirmation by microscopy or alternatively by RDTs [rapid diagnostic tests] is …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012